USANA Health Sciences Management

Management Kriterienprüfungen 3/4

USANA Health Sciences' CEO ist Jim Brown , ernannt in Nov 2016, hat eine Amtszeit von 7.58 Jahren. Die jährliche Gesamtvergütung beträgt $2.47M , bestehend aus 28.7% Gehalt und 71.3% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.051% der Aktien des Unternehmens, im Wert von $438.41K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 7.3 Jahre bzw. 6.3 Jahre.

Wichtige Informationen

Jim Brown

Geschäftsführender

US$2.5m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts28.7%
Amtszeit als Geschäftsführer7.6yrs
Eigentum des Geschäftsführers0.05%
Durchschnittliche Amtszeit des Managements7.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder6.3yrs

Jüngste Management Updates

Recent updates

USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

May 29
USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 03
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

May 01
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

Apr 04
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

May 31
Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Apr 28

Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

Mar 05
Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

USANA: 15x P/E, 14% Net Cash, Stock Repurchases

Feb 17

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Jim Brown im Vergleich zu den Einnahmen von USANA Health Sciences verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 30 2024n/an/a

US$62m

Dec 30 2023US$2mUS$710k

US$64m

Sep 30 2023n/an/a

US$60m

Jul 01 2023n/an/a

US$63m

Apr 01 2023n/an/a

US$65m

Dec 31 2022US$2mUS$624k

US$69m

Oct 01 2022n/an/a

US$77m

Jul 02 2022n/an/a

US$89m

Apr 02 2022n/an/a

US$108m

Jan 01 2022US$2mUS$600k

US$117m

Oct 02 2021n/an/a

US$136m

Jul 03 2021n/an/a

US$139m

Apr 03 2021n/an/a

US$129m

Jan 02 2021US$2mUS$599k

US$125m

Sep 26 2020n/an/a

US$116m

Jun 27 2020n/an/a

US$110m

Mar 28 2020n/an/a

US$103m

Dec 28 2019US$2mUS$559k

US$101m

Sep 28 2019n/an/a

US$102m

Jun 29 2019n/an/a

US$109m

Mar 30 2019n/an/a

US$121m

Dec 29 2018US$2mUS$534k

US$126m

Sep 29 2018n/an/a

US$88m

Jun 30 2018n/an/a

US$81m

Mar 31 2018n/an/a

US$70m

Dec 30 2017US$1mUS$523k

US$63m

Vergütung im Vergleich zum Markt: JimDie Gesamtvergütung ($USD2.47M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD3.37M).

Entschädigung vs. Einkommen: JimDie Bezüge der Mitarbeiter sind um mehr als 20 % gestiegen, während die Unternehmensgewinne im vergangenen Jahr um mehr als 20 % gesunken sind.


Geschäftsführer

Jim Brown (55 yo)

7.6yrs

Amtszeit

US$2,472,017

Vergütung

Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Kevin Guest
Executive Chairman7.1yrsUS$3.91m0.064%
$ 554.2k
Jim Brown
CEO & President7.6yrsUS$2.47m0.051%
$ 439.6k
G. Hekking
Chief Financial Officer7.1yrsUS$1.47m0%
$ 0
Walter Noot
Chief Operating Officer4.7yrsUS$1.42mkeine Daten
P. Foukas
Chief Legal Officer5.9yrsUS$1.29mkeine Daten
Daniel Macuga
Chief Communications & Marketing Officer12.5yrsUS$1.15m0%
$ 0
Myron Wentz
Founder & Chairman Emeritus32.4yrskeine Daten41.28%
$ 357.9m
John Cuomo
Executive Director of Product Development & Technology11.5yrskeine Datenkeine Daten
Robert Sinnott
Chief Scientific Officer7.8yrskeine Datenkeine Daten
Patrique Richards
Executive Director of Investor Relations & Business Developmentno datakeine Datenkeine Daten
Paul Jones
Chief People Officer3.3yrsUS$637.78k0.033%
$ 285.2k
Ashley Collins
Executive Vice President of Marketingno datakeine Datenkeine Daten

7.3yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrenes Management: USNADas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (7.3 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Kevin Guest
Executive Chairman7.1yrsUS$3.91m0.064%
$ 554.2k
Myron Wentz
Founder & Chairman Emeritus4.1yrskeine Daten41.28%
$ 357.9m
Gilbert Fuller
Lead Independent Director15.8yrsUS$251.60k0%
$ 0
Peggie Pelosi
Independent Director5.5yrsUS$231.40k0.018%
$ 152.3k
Timothy Wood
Independent Director4.7yrsUS$218.40k0.028%
$ 239.0k
Christine Wood
Member of Scientific Advisory Councilno datakeine Datenkeine Daten
Monica Lewis
Member of Scientific Advisory Councilno datakeine Datenkeine Daten
Peter Rugg
Chairperson of Scientific Advisory Council20.4yrskeine Datenkeine Daten
Bart Moore
Member of Scientific Advisory Councilno datakeine Datenkeine Daten
Heather Tick
Member of Scientific Advisory Councilno datakeine Datenkeine Daten
Frederic Winssinger
Independent Director8.1yrsUS$233.60k0.017%
$ 144.4k
J. Nixon
Independent Director1.9yrsUS$218.40k0.015%
$ 131.3k

6.3yrs

Durchschnittliche Betriebszugehörigkeit

68yo

Durchschnittliches Alter

Erfahrener Vorstand: USNADie Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).